These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9191180)

  • 21. Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation.
    Gimsa U; Mitchison NA; Brunner-Weinzierl MC
    Mediators Inflamm; 2013; 2013():320519. PubMed ID: 24023412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fate of intercellular MHC-peptide-T-cell receptor complexes during T-cell activation.
    Clark BR
    J Mol Recognit; 1995; 8(1-2):63-6. PubMed ID: 7598954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglia, macrophages and the blood-brain barrier.
    Graeber MB
    Clin Neuropathol; 1993; 12(5):296-7. PubMed ID: 8222403
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro.
    Risau W; Engelhardt B; Wekerle H
    J Cell Biol; 1990 May; 110(5):1757-66. PubMed ID: 1692329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that macrophages are programmed to die after activating autologous, cloned, antigen-specific, CD4+ T cells.
    Richardson BC; Buckmaster T; Keren DF; Johnson KJ
    Eur J Immunol; 1993 Jul; 23(7):1450-5. PubMed ID: 8100771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autologous mixed lymphocyte reaction in myasthenia gravis].
    Chiu HC; Hsieh KH; Hung TP
    Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):271-5. PubMed ID: 2955076
    [No Abstract]   [Full Text] [Related]  

  • 27. Dendritic cells and macrophages as antigen presenting cells in ovalbumin-induced T lymphocyte proliferation in vitro.
    Kapsenberg ML; Stiekema FE; Teunissen MB
    Adv Exp Med Biol; 1985; 186():389-94. PubMed ID: 3876708
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes.
    Balabanov R; Beaumont T; Dore-Duffy P
    J Neurosci Res; 1999 Mar; 55(5):578-87. PubMed ID: 10082080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis.
    Hammarström L; Smith E; Möller E; Franksson C; Matell G; Von Reis G
    Clin Exp Immunol; 1975 Aug; 21(2):202-15. PubMed ID: 1081023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update.
    Merrill JE; Graves MC; Mulder DG
    West J Med; 1992 Jun; 156(6):639-46. PubMed ID: 1319627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell cooperation in haploidentical bone marrow transplant recipient.
    Geha RS
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):117-21. PubMed ID: 3321639
    [No Abstract]   [Full Text] [Related]  

  • 32. Two signal models of lymphocyte activation?
    Langman RE; Cohn M
    Immunol Today; 1993 May; 14(5):235-7. PubMed ID: 8100136
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological function of the blood-cerebrospinal fluid barrier.
    Nathanson JA; Chun LL
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1684-8. PubMed ID: 2784211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte activation in experimental autoimmune myasthenia gravis.
    De Baets MH; Einarson B; Lindstrom JM; Weigle WO
    J Immunol; 1982 May; 128(5):2228-35. PubMed ID: 6977589
    [No Abstract]   [Full Text] [Related]  

  • 36. The Choroid Plexus Functions as a Niche for T-Cell Stimulation Within the Central Nervous System.
    Strominger I; Elyahu Y; Berner O; Reckhow J; Mittal K; Nemirovsky A; Monsonego A
    Front Immunol; 2018; 9():1066. PubMed ID: 29868025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of lymphoid microenvironments in human diseases--a short review.
    Janossy G; Bofill M
    Adv Exp Med Biol; 1985; 186():879-87. PubMed ID: 3901695
    [No Abstract]   [Full Text] [Related]  

  • 38. Is damage in central nervous system due to inflammation?
    Chavarria A; Alcocer-Varela J
    Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of accessory cells.
    Erb P; Ramila G; Studer S; Loeffler H; Cecka JM; Conscience JF; Feldmann M
    Immunobiology; 1984 Dec; 168(3-5):141-53. PubMed ID: 6241596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.